New studies demonstrate infection control strategies for measles and mumps outbreaks

The decline in vaccination rates across communities has led to the resurgence of diseases like measles and mumps, and recent outbreaks have demonstrated the importance of an integrated infection prevention response, according to new research presented at the 45th Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC). In a 2017 measles outbreak, there were 75 […]

Continue reading »

Newly-approved therapy provides improved quality of life for midgut neuroendocrine tumor patients

Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy. The injection consists of a somatostatin analog combined with a radioactive isotope that directly targets neuroendocrine […]

Continue reading »

Finally, hope for a syphilis vaccine

Despite efforts to eradicate it, syphilis is on the rise. Until now, most health agencies focused on treating infected people and their sex partners but new discoveries may make a vaccine possible, UConn Health researchers report in the 12 June issue of mBio. The World Health Organization estimates that 10.7 million people between the ages of 15 and 49 had […]

Continue reading »

Scientists help identify genetic markers for prostate cancer in global DNA download

An international team of researchers including USC scientists has found scores of new genetic markers in DNA code that increase prostate cancer risk—powerful knowledge likely to prove useful to detect and prevent the disease. Focusing on DNA of more than 140,000 men worldwide, researchers were able to identify 63 new genetic markers associated with prostate cancer risk. That greatly increases […]

Continue reading »

Possible new treatment for spinal cord injuries identified in animal studies

An experimental drug has shown promise as a potential therapy for spinal cord injuries in animal studies. The compound, 4-aminopyridine-3-methanol, works in a similar way as a drug previously developed at Purdue, 4-aminopyridine (4-AP), which has been approved by the U.S. Food and Drug Administration to treat multiple sclerosis. Dr. Riyi Shi, professor in the Department of Basic Medical Sciences, […]

Continue reading »
1 29 30 31 32 33 42